U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Structurally Diverse
Created
by admin
on Fri Dec 15 19:20:27 GMT 2023
Edited
by admin
on Fri Dec 15 19:20:27 GMT 2023
Source Materials Class ORGANISM
Source Materials Type VIRUS
Organism Family Herpesviridae
Organism Genus Cytomegalovirus
Organism Species human herpesvirus 5
Author NONE
Part WHOLE
Record UNII
7COI029E6K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HUMAN HERPESVIRUS 5
Common Name English
Human CMV
Common Name English
HHV-5
Common Name English
CMV
Common Name English
CYTOMEGALOVIRUS
Common Name English
CYTOMEGALOVIRUS HUMAN HERPESVIRUS 5 WHOLE
Common Name English
HCMV
Common Name English
HUMAN CYTOMEGALOVIRUS
Common Name English
Code System Code Type Description
FDA UNII
7COI029E6K
Created by admin on Fri Dec 15 19:20:27 GMT 2023 , Edited by admin on Fri Dec 15 19:20:27 GMT 2023
PRIMARY
NCI_THESAURUS
C14196
Created by admin on Fri Dec 15 19:20:27 GMT 2023 , Edited by admin on Fri Dec 15 19:20:27 GMT 2023
PRIMARY
DAILYMED
7COI029E6K
Created by admin on Fri Dec 15 19:20:27 GMT 2023 , Edited by admin on Fri Dec 15 19:20:27 GMT 2023
PRIMARY
Related Record Type Details
Structure of LOBUCAVIR
INHIBITOR->TARGET ORGANISM
VCL-6365
VACCINE ANTIGEN->TARGET ORGANISM
Structure of LETERMOVIR
INHIBITOR->TARGET ORGANISM
Structure of MARIBAVIR
INHIBITOR->TARGET ORGANISM
VCL-6520
VACCINE ANTIGEN->TARGET ORGANISM
Structure of FILOCICLOVIR
INHIBITOR->TARGET ORGANISM
REGAVIRUMAB
INHIBITOR->TARGET ORGANISM
LJP-538
INHIBITOR->TARGET ORGANISM
Posoleucel
INHIBITOR->TARGET ORGANISM
T-cells to eliminate actively expressing cells and provide T-cell help for antibody production
Structure of TOMEGLOVIR
INHIBITOR->TARGET ORGANISM
Structure of CIDOFOVIR ANHYDROUS
INHIBITOR->TARGET ORGANISM
IC50
SEVIRUMAB
INHIBITOR->TARGET ORGANISM
VCL-6368
VACCINE ANTIGEN->TARGET ORGANISM
HCMV GB PROTEIN
VACCINE ANTIGEN->TARGET ORGANISM
HCMVA (pp65) Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa phosphoprotein (pp65) of Human Cytomegalovirus (HCMV)
VACCINE ANTIGEN->TARGET ORGANISM
Structure of GANCICLOVIR
INHIBITOR->TARGET ORGANISM
Related Record Type Details
HUMAN HERPESVIRUS 5
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966